Galanin(1-13)-Gln14-bradykinin(2-9)amide is a chimeric peptide combining two bioactive domains to explore multi-motif interaction principles. Its hybrid sequence supports conformational and receptor-binding studies. Aromatic and charged residues create diverse interaction surfaces. Researchers apply it to probe modular peptide engineering.
CAT No: R0884
CAS No:860790-38-1
Synonyms/Alias:860790-38-1;M617;GLY-TRP-THR-LEU-ASN-SER-ALA-GLY-TYR-LEU-LEU-GLY-PRO-GLN-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG-NH2;M617 acetate;M617 TFA;KJB79038;AKOS024457245;DA-55143;PD079343;TS-10546;Alternative Name: Galanin(1-13)-Gln14-bradykinin(2-9)amide;
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.